chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Moderna product on 03/08/2021 and 04/05/2021. They had a symptom onset of approx 11/04/2021 and presented to emergency department on 11/06/2021 with primary complaint of shortness of breath, cough, and weakness, also a UTI that started approx 11/04/2021. They were admitted to hospital on 11/06/2021 and tested positive for COVID-19 twice on specimens collected 11/06/2021. The individual was found to have pneumonia. EKG showed sinus tachycardia and left bundle branch block that was stable (unchanged) from previous work up. The individual became suddenly and unexpectedly bradycardic while shifting position in bed with assistance and pulse was lost. The individual was a Do Not Resuscitate and death was called  on 11/06/2021.
COVID arm developed on day 8 after injection. Rash, swollen, itching and soreness
Patient reported to urgent care with left-sided chest pain with left arm weakness. Patient evaluated by Dr. called 911 and sent to  Hospital, via ambulance. Follow-up appointment scheduled.
This case was reported by a consumer via call center representative and described the occurrence of lost consciousness in a 18-year-old female patient who received BEXSERO. Concurrent medical conditions included iron decreased (the patient experienced low iron for 2 years and she takes iron therapy). Concomitant products included ALYACEN and LEXAPRO. On 2nd August 2016, the patient received the 1st dose of BEXSERO 1 ml. On 2nd August 2016, immediately after receiving BEXSERO, the patient experienced lost consciousness (serious criteria GSK medically significant), unresponsive to stimuli (serious criteria GSK medically significant), pallor and tremor. On 2nd August 2016, the outcome of the lost consciousness, unresponsive to stimuli, pallor and tremor were recovered/resolved. It was unknown if the reporter considered the lost consciousness, unresponsive to stimuli, pallor and tremor to be related to BEXSERO. Additional details were provided as follows: This case was reported by the patient's mother. The patient is a long distance runner, so her diastolic pressure tends to run low. Almost immediately after vaccination with BEXSERO, the patient turned white (pale), started shaking and lost her consciousness. The healthcare professional laid the patient down and she was unresponsive for approximately 3 to 4 minutes. Her blood pressure dropped to 58/48 and her pulse rate was decreased. The patient was monitored in the physician's office, then 30 minutes later her blood pressure again dropped and she lost consciousness again for 3 to 4 minutes. The patient was monitored for 2.5 hours following this episode. Her blood pressure then returned to normal and she was discharged. The patient's mother did not have vaccine lot number or expiration date.
This case was reported by a consumer and described the occurrence of influenza-like symptoms in a 54-year-old female patient who received Flu vaccine. Concurrent medical conditions included systemic lupus erythematous and fibromyalgia. In October 2012, the patient received Flu vaccine (intramuscular). In 2012, less than a month after receiving Flu vaccine, the patient experienced nausea, sweating and headache. In October 2012, the patient experienced influenza-like symptoms and feeling unwell. The patient was treated with OTC nausea medication and vitamin D nos. In January 2013, the outcome of the influenza-like symptoms, feeling unwell, nausea, sweating and headache were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms, feeling unwell, nausea, sweating and headache to be related to Flu vaccine. Additional information: This patient received an unknown flu vaccination and developed flu-like symptoms that came and went several times. She described the symptoms as sweating, nausea, headache and just not feeling good. She stated that the symptoms would last about 1.5 days and then come and go. In July 2013, she was diagnosed with Lupus and fibromyalgia so she believes it is possible the symptoms were actually caused by these conditions and not related to the flu vaccination.
Information has been received from a physician concerning a 23 year old female who in December 2006, was vaccinated with a second dose of Gardasil (yeast). In December 2006, the patient's blood pressure went up and she developed shortness of breath. After 30 minutes, the patient's blood pressure returned to normal. The patient was not pregnant. At the time of this report, the outcome of the shortness of breath was unknown. Additional information has been requested.
Continued off and on heavy periods/heavy bleeding...this started on 2 June....about two months after receiving the J&J COVID shot (4 Apr)
Foster parent reported vaccine administration error. Per the foster mom on 7/15/2023, the foster parents went into pharmacy store for patient's COVID-19 vaccine, and the foster dad went in to receive his shingles vaccine. Foster parent reports pharmacy stated to her the shingles vaccine needle (intended for patient's foster dad) ?poked? patient, but pharmacy withdrew the needle and did not administer the actual shingles vaccines. Pharmacy states the needle only poked patient.
Flushed 15-20 min. after vaccination; monitored for additional 15-20 min.
Case number PHEH2014US022228 is an initial spontaneous report from the consumer via Pharmacy received on 04 Nov 2014. This report refers to a female patient of an unknown age. She was vaccinated with FLUVIRIN (batch number: 1412401) at a dose of 0.5 ml in her right arm on an unknown date. On 24 Oct 2014, after vaccination she experienced right arm redness, swelling, pain and could not move her arm. She was diagnosed with cellulitis and was given medication (unspecified). The final outcome, seriousness and causality of the events were not reported. Seriousness assessment of (cellulitis and injected limb mobility decreased) was upgraded based on the NVx key event list.
Immediately post COVID vaccination to left deltoid site developed bleeding and noted a 5.5 cm hematoma. Guaze wrap and ice pack applied.   Patient denied discomfort. Observed for 10 minutes and no other adverse effects noted.   Patient instructed to monitor for worsening of hematoma. Notify provider of any concerns.
Patient (5 years old) came to the clinic and received the BIVALENT 5-11 YEAR OLD pfizer as the SECOND shot in the primary series instead of the MONOVALENT 5-11 year old pfizer.
Two weeks after receiving the 1st dose my eyes became irritated. I assumed it was dry eye, since they were not red, and used artificial tears. That didn?t work,  so I visited my optometrist. He said it was likely an inflammatory reaction to something and told me to use Zatidor drops. The drops helped tremendously. I was still using them when I received the second dose on 7/2/2021, but the irritation was under control with the drops. Within 30 minutes of receiving the second dose, my eyes were extremely irritated, light sensitive, watering, and red.  I sent a text and photo to my optometrist and he told me to take a Benadryl and use the eyes drops. The next morning the redness was gone. My eyes still felt irritated and I kept using the Zatidor drops twice a day. When I stopped using them the redness returned so I started again.  My left eye still feels irritated & I?m still using the drops in it, but the right eye is fine.  I?m not sure that this is related to the vaccine or not. If definitely got much worse within 30 minutes of getting the second dose, but it seems to be going on too long to have been an allergic reaction to the vaccine.
Wheezing and fever, followed by rash on 9/15/2015. Declined medical treatment and took Benadryl at home.
Getting from rashes in different area; Severe allergic reaction; I did get a bad rash with in a few minutes of vaccine; This is a spontaneous report from a contactable consumer. This 54-year-old female consumer (patient) reported that. A 54-years-old female patient received (BNT162B2, formulation: Solution for injection, Lot Number: EN6204), via an unspecified route of administration on Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported she have concern because getting from rashes in different area. she had the COVID-19 Vaccination on Friday, and she was looking at the severe allergic reaction. She did get a bad rash within a few minutes of vaccine. The patient experienced getting from rashes in different area, severe allergic reaction; I did get a bad rash within a few minutes of vaccine onMar2021. Reporter stated, my sister recommended to take it and it doesn't feel like severe. No treatment was received for the events. The clinical outcome of the events were unknown.  No follow-up attempts are possible. No further information is expected.
Localized tenderness immediately increasing to deltoid pain with forward flexion, crossbody adduction. Increasing in severity past 1-2 weeks.
half dollar size swelling at the injection site with mild erythema and tenderness. No treatment needed. Swelling and tenderness is going down over time.
at 18:30 on 2/28/2020 received my second shingles vaccine. (Zoster Vaccine (Recombinant)) Went home and ate dinner at about 19:30. Was feeling drowsy so sat in front of the television and fell asleep. Woke up about 20:45 and had no hearing in my right ear and kind of a low humming noise. Tried to clear my ears by holding my nose and blowing hard. There was no improvement. Called my dad, who is a retired MD and asked him what I should do. He advised me to go to the ER. Arrived at ER at approximately 21:45. They did some hearing tests and ordered an MRI Brain w wo Contrast. They did not find anything that would cause hearing loss. Hearing improved over the next 48 hours to pre-incident levels. Ordered a follow-up appointment with ENT. scheduled for Friday 3/6 @ 2:45.
It started with body aches. Then I started to get headaches. And it was so severe, I was going to go to the hospital but I knew they were not going to do anything. The pain was about at an 8. It was so bad I was screaming and crying for 4 days, until I took the pain pain oxy to make it stop. This started on a Friday and my doctor was only available come Monday. It was so severe I told my doctor I would not take another vaccine unless he gave me pain pills. He would not so I refuse now to take the next vaccine.
Ct. reports she was not able to sleep on 10/8/18 due to vaccination. One or two days later, she began to experience fever, chills, muscle aches, joint pain, decreased appetite, diarrhea, stiffness and skeletal pain. She also reports nose bleed for one week. All other symptoms beginning on 10/9/18 or 10/10/18 have continued.
I am allergic to polyethylene glycol ?  it actually put me in the hospital for years ago. I had no idea it was in the vaccine, although a smaller amount than I had taken before. I started experiencing severe and awful anxiety and panic that night I got the vaccine. I had other minor side effects that were expected but they went away within a day. Several days later, I began experiencing pain in both my bilateral Achilles tendons and bilateral knee pain. A physical therapist examined both and said that I was swollen. I have had both of those problems under control for a very long time. I am improving somewhat  but nearly 2 weeks later I am still having some repercussions. I am now scared and don't know if I should get the second injection done because the previous adverse symptoms were awful. Thank you.
Few in swollen diameter. Red, purple, yellow & raised around injection site. Looks like blisters forming 3 days after injection.
First flu shot received, she felt pulse beating at her inner elbow.  Passed after waiting 20 minutes.  Felt a little tired and achy the next day.  Advised by hotline nurse to take Tylenol or Advil.
no symptomatic adverse events were reported; administration of expired MMR-II; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported.   On 09-MAY-2023, the patient was administrated with expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (therapy type: recombinant Human albumin (rHA), 0.5 ml/once, lot #U011995, expiration date: 15-APR-2023; route of administration was not provided) for prophylaxis. Sterile diluent (MERCK STERILE DILUENT) (lot # U024490, expiration date: 02-NOV-2023) was used to reconstitute measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II).  The reporter confirmed that no symptomatic adverse events were reported and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) did not have any temperature excursions in its lifetime.
Hives on face, neck, chest, back arms, and legs began night after vaccination, spread over 2-3 days, treated with Benadryl.
On set of substernal chest pain and sweating 2 hours after administration of the vaccine. Patient returned to clinic 24 hours later with continued pain . Reported mild cough. Vitals stable except for mild tachycardia at 109 and temperature of 100.3. Normal EKG except for sinus tach. Patient transferred to ER via EMS due to chest pain with risk factors including positive cardiac family hx, age and male.
After receiving Hep B vaccine client fainted but was responsive in a few seconds.  PHN observed client and checked vital signs every ten minutes.  Client stood up to leave clinic and fell on floor again regaining consciousness in a few seconds.  PHN continued to monitor vital signs.  Color pale, client oriented, alert and responsive.  Benadryl 25 mg given IM.  EMS activated.  Oxygen started.  Mom requested client be transported to hospital for observation.
10/8/09 Coughing, wheezing- Asthma exacerbation - Albuterol Nu 94 L/c.
Received her 1st covid vaccine at noon on 2/19/21.  Woke later that night in middle of the night with bleeding from right nostril and severe right ear pain
14Mar96 pt recv 1 dose vax. 21Feb98 pt devel less than 50 lesions,very small, mostly on his neck & trunk. Pt was afebrile.
I had a sinus headache, sinus pressure, and a sore throat. I also had coughing, sneezing, malaise, and fatigue. I also lost my taste and smell. I completed a COVID-19 home test the next day and it was positive. I let my doctor know. By Friday I was feeling extremely ill. I was not able to sleep at night due to coughing. I received a prescription for PAXLOVID and started it on December 03, 2022. My symptoms lingered for about 3 weeks. I started to have some gastrointestinal issues as well. I tested negative on December 10, 2022. I still have headache and cough currently. I do feel that I have recovered. Definitely from the intense.
On 10/18 her arm was painful, red and swollen. She also had fever, body aches throughout 10/18, 10/19, 10/20 & 10/21. She was also nauseous. When she presented to me on 10/21 her arm was red and splotchy. I referred immediately to MD and called MD and he prescribed Keflex. She also went to MD that night and he confirmed Cellulitis and said Keflex ok.
Patient was seen 6/24 in ER for GERD - pain same area where shingles rash appeared on 6/28. Shingles vaccine given 6/25. Rash appeared 6/28 - acyclovir 800 mg 5x a day started. Pt has follow up appt on 7/5/12.
Rapid onset vision loss in left eye with concurrent rapid onset high blood pressure and rapid pulse.  Testing showed existing crowded optic nerve (previously undiagnosed), swelling of the optic nerve, delayed blood flow to optic nerve, and leakage around optic nerve head.  Vision loss progressed over about five days, stabilized, and may now be somewhat improved.  Diagnosis is Non-Arteric Ischemic Optic Neuritis (NAION), for which there is no treatment and uncertain prognosis.  Some extent of permanent vision loss tis epected.  Concurrent rapid onset of hypertension (systolic 150s-170s; diastolic low 100s at times) and fluctuating rapid pulse (80s-110). Currently being treated for hypertension but not yet fully controlled.  Blood tests revealed elevated inflammatory markers (high C-reactive protein and sedimentation rate and positive ANA.  Follow-up tests to determine cause of hypertension are underway.  Thus far, no heart abnormalities, no carotid artery blockage, and negative for a number of autoimmune disorders and other possible causes.  Prior to this event, blood pressure and pulse were normal and eye exams showed no vision or retina problems, glaucoma, or macular degeneration.  Cardiologist and rheumatologist have not ruled out inflammatory response to Covid vaccine, have encouraged reporting of this event to VAERS, and have advised against taking any other Covid booster.   Note that the optometrist who first saw me when the vision loss began has since told me that he saw only two cases of NAION in 38 years of practice before mine, but has seen two more besides me in the last couple of months.  Both were patients of similar age with similar rapid onset of vision loss, and both had taken the Covid vaccine about four weeks before.
This literature marketed report as received from the authors of the published article, refers to a 76 year-old male patient. His past medical history was significant for a recent episode of allergic contact dermatitis due to poison ivy, which was managed by his primary care physician with a short seven-day taper of oral methylprednisolone. On an unknown date, within a couple days of completing the methylprednisolone taper, the patient received the Zoster Vaccine Live (manufacturer unknown) (VZV vaccine) (medication error), which was administered subcutaneously into the left upper extremity (dose, lot # and expiration date were not provided). On an unknown date (reported as subsequently), he developed the vesicular rash seven days after receiving the vaccine. On an unknown date, the patient presented with a three day history of a vesicular rash localized to the left lateral neck, shoulder, and proximal upper extremity. The rash was not accompanied by pruritus, burning, or pain. Additionally, the patient denied experiencing prodrome symptoms, such as paresthesia, pain, burning, and/or pruritus, prior to developing the cutaneous eruption. Review of systems was unremarkable. On an unknown date, physical exam findings were significant for a confluent, erythematous, vesicular eruption in a dermatomal distribution on the left inferior/lateral neck, left clavicle, left shoulder and proximal upper extremity. These findings were consistent with herpes zoster (aka, shingles) (vaccination failure). The patient was immediately started on a seven-day course of oral valacyclovir. Since the rash was asymptomatic, no topical anti-inflammatory medications were prescribed. The patient reported improvement in the eruption within 2-3 days of starting oral valacyclovir. The rash remained asymptomatic. Of note, after starting valacyclovir, the patient indicated that he experienced mild, intermittent left-sided headaches, which resolved with over-the-counter ibuprofen. Otherwise, his review of systems remained unremarkable. Of note, no samples were collected from the rash to determine if the varicella zoster virus was derived from the vaccine versus a wild-type strain. The outcome of the event was considered to be recovering/resolving. The authors considered the event of herpes zoster to be related to the therapy with Zoster Vaccine Live (manufacturer unknown) as the herpes zoster developed shortly after vaccination. Follow up was received on 22-FEB-2016, which is prior to the previously submitted aware date 23-FEB-2016. Hence case # US-009507513-1602USA010954 is being deleted from our files and submitted under new case US-009507513-1603USA000296. Expiration date of the suspect product zoster vaccine live (manufacturer unknown) was reported to be 13-MAR-2016. Additional information has been requested.
Firm 3x4cm nodule, tender to touch with surrounding ecchymosis on day 3 after injection. Resolved except for slight tenderness 12 days after injection. Pt tx'd with BENADRYL.
Febrile seizure 30 seconds, seen by EMS, transported to hospital, tx: Ibuprofen dx : viral illness d/c home
Sudden behavior change.  Decrease in speech and interaction.  More fearful with more crying for past month.
lump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump at the injection site) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A, 029L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Aug-2021, the patient experienced VACCINATION SITE MASS (lump at the injection site). At the time of the report, VACCINATION SITE MASS (lump at the injection site) outcome was unknown.            Concomitant and Treatment was not specified.   This case was linked to MOD-2021-336394 (Patient Link).
My second Pfizer vaccine was given on 2-10-21. I did not have any problems until about two weeks later when I started experiencing balance impairment issues and light-headedness.  My primary doctor ordered an MRI, which came back normal.  I was then sent to an audiologist to determine if this could be an inner ear issue.  That test was normal.  However, the audiologist recommended that I undergo VNG testing, which I am scheduled to do at an audiology lab at the Hospital on Oct. 20, 2021. I am also undergoing vestibular physical therapy.  I am now worried if this problem could be magnified by the booster, which I would be eligible for because of my age, 72..
Pt recv vax on 12/15/98; on 12/16/98 pt exp head pressure, blurred vision, equilibrium off, dizziness & nausea
9 days after shot left arm vacc site appeared red, warm in strip about 3" wide and sore to touch.  (Initial soreness had disappeared 2-3 days after shot). Had virtual visit w primary's NP,  site viewed. Determined to be "Covid arm" since no other symptoms present. Ice pack used. Redness slightly increased but lighter in color on 2/15.
Temp elevated during 31JUL91 PM to 103 AX; 1AUG91 830AM sz activity noted; Seen in ER by MD-stabililzed & released to parents; MD states placed pt on amoxicillin for lung congestion that AM;
Patient started experiencing numbness and droopiness from her right cheek upwards towards her eye. No other symptoms or alteration of her vision. Patient was checked for signs of a stroke to which there were none.
a mild rash exactly one month later.  Raised red bumps on her torso, approx 20
Notified by mother that patient was unresponsive and called ambulance.  Resulted in deceased patient.
The patient experienced no symptoms; a dose of Rotateq was administered to a patient who is 36 weeks and 4 days old; This spontaneous report was received from a nurse and refers to a 36 weeks and 4 days old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 29-JAN-2020, the patient was administered a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), orally, lot # R033251, expiration date 29-JUN-2020 (dose was not provided), for prophylaxis (Inappropriate schedule of vaccine administered). The patient experienced no symptoms. The outcome of the event was unknown.